GLP-1 Induces the Expression of FNDC5 Derivatives That Execute Lipolytic Actions
Multiple GLP-1-derived therapeutics are clinically used to treat type 2 diabetes and obesity. However, the underlying mechanism of how these drugs regulate the body weight of obese patients remains incompletely understood. Here, we report that the lipolysis effects of GLP-1 on β cells can depend on...
Saved in:
Main Authors: | Hui Li, William Donelan, Fang Wang, Peilan Zhang, Lijun Yang, Yousong Ding, Dongqi Tang, Shiwu Li |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/7bdb554328d646d6b1fcf7fdac2da5a2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exercise Enhanced Cardiac Function in Mice With Radiation-Induced Heart Disease via the FNDC5/Irisin-Dependent Mitochondrial Turnover Pathway
by: Wuyang He, et al.
Published: (2021) -
Anti-Obesity Effect of α-Cubebenol Isolated from <i>Schisandra chinensis</i> in 3T3-L1 Adipocytes
by: Su Jin Lee, et al.
Published: (2021) -
Lipolytic bacteria and the dynamics of flavor production in Indonesian tempeh
by: Naswandi Nur, et al.
Published: (2020) -
miR-377 inhibition enhances the survival of trophoblast cells via upregulation of FNDC5 in gestational diabetes mellitus
by: Hua Zhaozhao, et al.
Published: (2021) -
Emerging role of GLP-1 receptor agonists in the treatment of obesity
by: Neff LM
Published: (2010)